CareView Communications (CRVW) Cash from Financing Activities (2010 - 2024)
CareView Communications' (CRVW) quarterly Cash from Financing Activities came in at -$2171.0 in Q3 2024, up 38.36% year-over-year from -$1569.1 in Q4 2023, and up 7.58% quarter-over-quarter from -$2349.0 in Q2 2024.
Powered by 
Analysis
CareView Communications (CRVW) Cash from Financing Activities (2010 - 2024) Analysis & Trends
CareView Communications has disclosed Cash from Financing Activities across 15 years of filings, most recently posting -$2171.0 for Q3 2024.
- In Q3 2024, Cash from Financing Activities rose 38.36% year-over-year to -$2171.0; the TTM figure through Jun 2025 stood at -$2171.0 (up 84.66% YoY), while the FY2024 annual figure was -$8042.0, up 47.91% from the prior year.
- Cash from Financing Activities came in at -$2171.0 for Q3 2024 at CareView Communications, up from -$2349.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $681800.0 in Q2 2020 to a low of -$51174.0 in Q3 2021.
- Average Cash from Financing Activities over 5 years is $69140.7, with a median of -$3523.0 recorded in 2022.
- Year-over-year, Cash from Financing Activities sank 109.09% in 2021 and surged 22094.8% in 2022.
- Over 5 years, Cash from Financing Activities stood at -$50000.0 in 2020, then soared by 102.35% to $1174.0 in 2021, then surged by 22094.8% to $260567.0 in 2022, then sank by 101.82% to -$4755.0 in 2023, then surged by 54.34% to -$2171.0 in 2024.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$2171.0 in Q3 2024, -$2349.0 in Q2 2024, and -$3522.0 in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | -263.16 Mn |
| 10 | CareView Communications | 23.36 Mn | 21.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -2,171.00 |
| Jun 30, 2024 | -2,349.00 |
| Mar 31, 2024 | -3,522.00 |
| Dec 31, 2023 | -4,755.00 |
| Sep 30, 2023 | -3,522.00 |
| Jun 30, 2023 | -3,523.00 |
| Mar 31, 2023 | -3,639.00 |
| Dec 31, 2022 | 260,567.00 |
| Sep 30, 2022 | -3,523.00 |
| Jun 30, 2022 | -3,523.00 |
| Mar 31, 2022 | -17,307.00 |
| Dec 31, 2021 | 1,174.00 |
| Sep 30, 2021 | -51,174.00 |
| Jun 30, 2021 | -50,000.00 |
| Mar 31, 2021 | -50,000.00 |
| Sep 30, 2020 | -50,000.00 |
| Jun 30, 2020 | 681,800.00 |
| Mar 31, 2020 | 550,000.00 |
| Sep 30, 2019 | -50,000.00 |
| Jun 30, 2019 | 200,000.00 |